Frequency of restrictive valvular heart disease in patients with Parkinson's disease treated with pergolide, an ergot-derived anti-parkinsonian drug: a case-control echocardiographic study

被引：0
|
作者：
Schlesinger, I
Katz, M
Aharon-Perez, J
Badarny, S
Bloch, I
Gross, B
Agmon, Y
机构：
[1] Rambam Med Ctr, Haifa, Israel
[2] Carmel Med Ctr, Afula, Israel
[3] Haemek Med Ctr, Nahariyya, Israel
[4] Western Galilee Hosp, Nahariyya, Israel
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] Valvular heart disease in patients with Parkinson's disease treated with pergolide
    Dupuy, D.
    Lesbre, J. P.
    Andrejak, M.
    Godefroy, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 59 - 59
  • [2] Valvular heart disease in patients with Parkinson's disease treated with pergolide
    Dupuy, D.
    Lesbre, J. P.
    Andrejak, M.
    Godefroy, O.
    DRUG SAFETY, 2006, 29 (10) : 1005 - 1005
  • [3] Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease
    Rasmussen, V. G.
    Poulsen, S. H.
    Dupont, E.
    Ostergaard, K.
    Safikhany, G.
    Egeblad, H.
    JOURNAL OF INTERNAL MEDICINE, 2008, 263 (01) : 90 - 98
  • [4] Heart valvular disease in patients with Parkinson's disease treated with Pergolide and/or Levodopa
    Ozer, F.
    Tiras, R.
    Cetin, S.
    Ozturk, O.
    Aydemir, T.
    Ozben, S.
    Meral, H.
    Kizkin, S.
    Bader, H.
    MOVEMENT DISORDERS, 2006, 21 : S518 - S518
  • [5] Valvular heart disease is rare in Parkinson's disease patients treated with pergolide
    Ruzicka, E.
    Linkova, H.
    Penicka, M.
    Roth, J.
    Ulmanova, O.
    Novakova, L.
    Havlikova, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 82 - 82
  • [6] Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both
    Ozer, Feriha
    Tiras, Raziye
    Cetin, Sibel
    Ozturk, Oya
    Aydemir, Tuba
    Ozben, Serkan
    Meral, Hasan
    Kizkin, Sibel
    Bader, Halit
    Ozben, Beste
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (01) : 83 - 87
  • [7] A long-term echocardiographic study of the course of valvular dysfunctions following discontinuation of ergot-derived dopamine agonists in patients with Parkinson's disease
    Serra, Walter
    Negrotti, Anna
    Marchesi, Elena
    Angelini, Monica
    Goldoni, Matteo
    Calzetti, Stefano
    IJC METABOLIC & ENDOCRINE, 2015, 6 : 27 - 30
  • [8] Clinically relevant valvular heart disease is rare in Parkinson's disease patients treated with pergolide
    Linkova, Hana
    Penicka, Martin
    Ruzicka, E.
    Roth, J.
    Ulmanova, O.
    Novakova, L.
    Havlikova, Martina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 303A - 303A
  • [9] Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide
    Van Camp, G
    Flamez, A
    Cosyns, B
    Goldstein, J
    Perdaens, C
    Schoors, D
    NEUROLOGY, 2003, 61 (06) : 859 - 861
  • [10] Valvular heart disease in patients with Parkinson’s disease treated with pergolide. Course following treatment modifications
    D. Dupuy
    J. P. Lesbre
    P. Gérard
    M. Andrejak
    O. Godefroy
    Journal of Neurology, 2008, 255
12345